John Yu
John Samuel Yu (; born 12 December 1934) is a Chinese-born Australian paediatrics doctor who served as CEO of the Royal Alexandra Hospital for Children from 1979 until 1997. He was the Australian of the Year for 1996. Provided by Wikipedia
Showing 1 - 14 results of 14 for search 'John Yu', query time: 0.03s
Refine Results
-
1
Bilingual, Intergenerational Worship and Ministry for Unity by John Yu
Published 2022-03-01
Article -
2
Locoregional tumor burden and risk of mortality in metastatic breast cancer by Sherry X. Yang, Stephen M. Hewitt, John Yu
Published 2022-04-01
Article -
3
-
4
The Puf-A Protein Is Required for Primordial Germ Cell Development by Chi-Fong Ko, Yi-Chieh Chang, Huan-Chieh Cho, John Yu
Published 2022-04-01
Article -
5
YULINK regulates vascular formation in zebrafish and HUVECs by Hsin-Hung Lin, Ming-Wei Kuo, Tan-Chi Fan, Alice L. Yu, John Yu
Published 2023-02-01
Article -
6
Genome sequencing and application of Taiwanese macaque Macaca cyclopis by Kuo-Ping Chiu, Lutimba Stuart, Hong Sain Ooi, John Yu, David Glenn Smith, Kurtis Jai-Chyi Pei
Published 2023-07-01
Article -
7
Correction: Santos, R.S., et al. Improvement of IFNγ ELISPOT Performance Following Overnight Resting of Frozen PBMC Samples Confirmed Through Rigorous Statistical Analysis. Cells... by Radleigh Santos, Alcinette Buying, Nazila Sabri, John Yu, Anthony Gringeri, James Bender, Sylvia Janetzki, Clemencia Pinilla, Valeria A. Judkowski
Published 2015-04-01
Article -
8
Improvement of IFNg ELISPOT Performance Following Overnight Resting of Frozen PBMC Samples Confirmed Through Rigorous Statistical Analysis by Radleigh Santos, Alcinette Buying, Nazila Sabri, John Yu, Anthony Gringeri, James Bender, Sylvia Janetzki, Clemencia Pinilla, Valeria A. Judkowski
Published 2014-12-01
Article -
9
-
10
-
11
The interplay between IGF-1R signaling and Hippo-YAP in breast cancer stem cells by Yu-Tzu Chan, Ruey-Jen Lin, Ya-Hui Wang, Tsai-Hsien Hung, Yenlin Huang, John Yu, Jyh-Cherng Yu, Alice L. Yu
Published 2023-04-01
Article -
12
High expression of embryonic stem cell marker SSEA3 confers poor prognosis and promotes epithelial mesenchymal transition in hepatocellular carcinomaAt a glance of commentary by Tsai-Hsien Hung, Yenlin Huang, Chau-Ting Yeh, Chun-Nan Yeh, John Yu, Chun-Cheng Lin, Shih-Pin Chiou, Pei-Yun Chiang, Jung-Tung Hung, Alice L. Yu
Published 2024-04-01
Article -
13
Whole genomic analysis reveals atypical non-homologous off-target large structural variants induced by CRISPR-Cas9-mediated genome editing by Hsiu-Hui Tsai, Hsiao-Jung Kao, Ming-Wei Kuo, Chin-Hsien Lin, Chun-Min Chang, Yi-Yin Chen, Hsiao-Huei Chen, Pui-Yan Kwok, Alice L. Yu, John Yu
Published 2023-08-01
Article -
14
Globo H Is a Promising Theranostic Marker for Intrahepatic Cholangiocarcinoma by Tsai‐Hsien Hung, Jung‐Tung Hung, Chiao‐En Wu, Yenlin Huang, Chien‐Wei Lee, Chau‐Ting Yeh, Yi‐Hsiu Chung, Fei‐Yun Lo, Li‐Chun Lai, John K. Tung, John Yu, Chun‐Nan Yeh, Alice L. Yu
Published 2022-01-01
Article